Editorial

Most Recent

image: Meeting of the Minds

Meeting of the Minds

By Mary Beth Aberlin | July 1, 2012

New changes at The Scientist will ensure that we continue to showcase the best and brightest ideas in the life sciences.

1 Comment

image: Avant-Garde Science

Avant-Garde Science

By Mary Beth Aberlin | June 1, 2012

Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.

0 Comments

image: With All Due Consideration

With All Due Consideration

By Mary Beth Aberlin | May 1, 2012

Scientists and their many hats

2 Comments

image: Agents Provocateurs

Agents Provocateurs

By Mary Beth Aberlin | April 1, 2012

Asking pointed questions is a key part of the scientific process.

3 Comments

image: Tricky Trials

Tricky Trials

By Mary Beth Aberlin | March 1, 2012

Studies on safety, efficacy, or dosing of drugs in children, or on nutritional supplements, are not run-of-the-mill.

0 Comments

image: On the Menu

On the Menu

By Mary Beth Aberlin | February 1, 2012

Digestion on the cellular level: two mysteries examined

0 Comments

image: In with the New

In with the New

By Mary Beth Aberlin | January 1, 2012

There is definitely no shortage of technological innovation in the life sciences.

0 Comments

A Truly Happy Return

By Mary Beth Aberlin | December 1, 2011

After a roller-coaster of an October, The Scientist resumes publication under new ownership.

12 Comments

. . . And Many Happy Returns

By Mary Beth Aberlin | October 1, 2011

To the great scientific leaps witnessed during our first 25 years, and the game changers yet to come.

0 Comments

image: Alive and Kicking

Alive and Kicking

By Eugene Garfield | October 1, 2011

The publication I launched a quarter century ago has come further than anyone ever expected.

27 Comments

Popular Now

  1. Two University of Rochester Professors Resign in Protest
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Koko the Signing Gorilla Dies at 46